These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12836025)

  • 1. The SLC40 basolateral iron transporter family (IREG1/ferroportin/MTP1).
    McKie AT; Barlow DJ
    Pflugers Arch; 2004 Feb; 447(5):801-6. PubMed ID: 12836025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammalian iron transporters: families SLC11 and SLC40.
    Montalbetti N; Simonin A; Kovacs G; Hediger MA
    Mol Aspects Med; 2013; 34(2-3):270-87. PubMed ID: 23506870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO/SLC7A11 pathway.
    Jiang T; Xiao Y; Zhou J; Luo Z; Yu L; Liao Q; Liu S; Qi X; Zhang H; Hou M; Miao W; Batsaikhan B; Damba T; Liang Y; Li Y; Zhou L
    Redox Biol; 2023 Dec; 68():102963. PubMed ID: 37984229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroportin Q248H mutation was not found to be protective against malaria and anemia in children under 5 years living in South Kivu/Democratic Republic of Congo, an endemic area of
    Bahati YL; Delanghe J; Balaluka GB; Vandepoele K; Cirhuza JC; Kishabongo AS; Philippé J
    Heliyon; 2022 Sep; 8(9):e10460. PubMed ID: 36060466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MagA expression attenuates iron export activity in undifferentiated multipotent P19 cells.
    Liu L; Alizadeh K; Donnelly SC; Dassanayake P; Hou TT; McGirr R; Thompson RT; Prato FS; Gelman N; Hoffman L; Goldhawk DE
    PLoS One; 2019; 14(6):e0217842. PubMed ID: 31170273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferroportin disease mutations influence manganese accumulation and cytotoxicity.
    Choi EK; Nguyen TT; Iwase S; Seo YA
    FASEB J; 2019 Feb; 33(2):2228-2240. PubMed ID: 30247984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Pumping iron"-how macrophages handle iron at the systemic, microenvironmental, and cellular levels.
    Nairz M; Theurl I; Swirski FK; Weiss G
    Pflugers Arch; 2017 Apr; 469(3-4):397-418. PubMed ID: 28251312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress and the homeodynamics of iron metabolism.
    Bresgen N; Eckl PM
    Biomolecules; 2015 May; 5(2):808-47. PubMed ID: 25970586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational modeling and analysis of iron release from macrophages.
    Potdar AA; Sarkar J; Das NK; Ghosh P; Gratzl M; Fox PL; Saidel GM
    PLoS Comput Biol; 2014 Jul; 10(7):e1003701. PubMed ID: 24991925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Concise Guide to PHARMACOLOGY 2013/14: transporters.
    Alexander SP; Benson HE; Faccenda E; Pawson AJ; Sharman JL; Spedding M; Peters JA; Harmar AJ;
    Br J Pharmacol; 2013 Dec; 170(8):1706-96. PubMed ID: 24528242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron metabolism: current facts and future directions.
    Tandara L; Salamunic I
    Biochem Med (Zagreb); 2012; 22(3):311-28. PubMed ID: 23092063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of iron transport.
    Byrne SL; Krishnamurthy D; Wessling-Resnick M
    Annu Rev Pharmacol Toxicol; 2013; 53():17-36. PubMed ID: 23020294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The iron transporter ferroportin can also function as a manganese exporter.
    Madejczyk MS; Ballatori N
    Biochim Biophys Acta; 2012 Mar; 1818(3):651-7. PubMed ID: 22178646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ferroportin in macrophage-mediated immunity.
    Johnson EE; Sandgren A; Cherayil BJ; Murray M; Wessling-Resnick M
    Infect Immun; 2010 Dec; 78(12):5099-106. PubMed ID: 20837712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferroportin and erythroid cells: an update.
    Cianetti L; Gabbianelli M; Sposi NM
    Adv Hematol; 2010; 2010():. PubMed ID: 20827391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferroportin and iron regulation in breast cancer progression and prognosis.
    Pinnix ZK; Miller LD; Wang W; D'Agostino R; Kute T; Willingham MC; Hatcher H; Tesfay L; Sui G; Di X; Torti SV; Torti FM
    Sci Transl Med; 2010 Aug; 2(43):43ra56. PubMed ID: 20686179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis and update of the human solute carrier (SLC) gene superfamily.
    He L; Vasiliou K; Nebert DW
    Hum Genomics; 2009 Jan; 3(2):195-206. PubMed ID: 19164095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differing expression of genes involved in non-transferrin iron transport across plasma membrane in various cell types under iron deficiency and excess.
    Balusikova K; Neubauerova J; Dostalikova-Cimburova M; Horak J; Kovar J
    Mol Cell Biochem; 2009 Jan; 321(1-2):123-33. PubMed ID: 18830567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunolocalization of ferroportin in healthy and anemic mice.
    D'Anna MC; Veuthey TV; Roque ME
    J Histochem Cytochem; 2009 Jan; 57(1):9-16. PubMed ID: 18796409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flatiron mice and ferroportin disease.
    Johnson EE; Wessling-Resnick M
    Nutr Rev; 2007 Jul; 65(7):341-5. PubMed ID: 17695375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.